NCT02930902
- Conditions
- Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7, Stage IA Pancreatic Cancer AJCC v6 and v7, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Stage IIA Pancreatic Cancer AJCC v6 and v7
Explore clinical trials studying Stage IIA Pancreatic Cancer AJCC v6 and v7. Study availability and eligibility vary by location and protocol.
4 public trials
0 recruiting studies
Stage IIA Pancreatic Cancer AJCC v6 and v7 trial results
NCT02394535
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- MD Anderson in Katy Houston, Texas, United States
- MD Anderson Cancer Center - League City League City, Texas, United States
- MD Anderson in Sugar Land Sugar Land, Texas, United States
Active, Not Recruiting
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
NCT02381561
- Conditions
- Advanced Bile Duct Carcinoma, Colonic Diseases, Colonic Neoplasms, +58 more
- Locations
-
- Rhode Island Hospital Providence, Rhode Island, United States
Active, Not Recruiting
Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer
NCT03073785
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +15 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States